NNovartis Read More Novartis MS treatment cuts rates of relapse in pivotal trials2026-10-23 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
RRoche Read More Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio2026-10-19 Phase III Krascendo 1 results demonstrated divarasib’s superiority over current standard of care, first-generation KRAS G12C inhibitors in…
RRoche Read More Roche, Celcuity unveil positive breast cancer studies2026-03-01 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…